# Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU

> **NCT07399054** · — · NOT_YET_RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 50 (estimated)

## Conditions studied

- Stress Ulcers
- Reflux Episodes

## Interventions

- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT07399054
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07399054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07399054, "Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07399054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*